SE505274C2 - Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning - Google Patents
Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösningInfo
- Publication number
- SE505274C2 SE505274C2 SE9503731A SE9503731A SE505274C2 SE 505274 C2 SE505274 C2 SE 505274C2 SE 9503731 A SE9503731 A SE 9503731A SE 9503731 A SE9503731 A SE 9503731A SE 505274 C2 SE505274 C2 SE 505274C2
- Authority
- SE
- Sweden
- Prior art keywords
- zeolite
- solution
- use according
- syringe
- hydrophobic
- Prior art date
Links
- 239000010457 zeolite Substances 0.000 title claims abstract description 101
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 229910021536 Zeolite Inorganic materials 0.000 title claims abstract description 77
- 230000002209 hydrophobic effect Effects 0.000 title claims abstract description 35
- 239000003755 preservative agent Substances 0.000 title claims abstract description 27
- 239000007924 injection Substances 0.000 title claims abstract description 14
- 238000002347 injection Methods 0.000 title claims abstract description 14
- 239000012460 protein solution Substances 0.000 title claims abstract description 5
- 229940079593 drug Drugs 0.000 title claims description 6
- 239000003814 drug Substances 0.000 title claims description 6
- 239000000243 solution Substances 0.000 claims abstract description 59
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 24
- 102000004877 Insulin Human genes 0.000 claims abstract description 12
- 108090001061 Insulin Proteins 0.000 claims abstract description 12
- 229940125396 insulin Drugs 0.000 claims abstract description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 21
- 238000001179 sorption measurement Methods 0.000 claims description 19
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 15
- 230000002335 preservative effect Effects 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims description 8
- 229930003836 cresol Natural products 0.000 claims description 8
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052680 mordenite Inorganic materials 0.000 claims description 3
- 229910017090 AlO 2 Inorganic materials 0.000 claims description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 2
- 102000018997 Growth Hormone Human genes 0.000 claims description 2
- 108010051696 Growth Hormone Proteins 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229960002798 cetrimide Drugs 0.000 claims description 2
- 229960003260 chlorhexidine Drugs 0.000 claims description 2
- -1 chlorobutol Chemical compound 0.000 claims description 2
- 239000000122 growth hormone Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 claims 2
- 241001640117 Callaeum Species 0.000 claims 1
- 229960000686 benzalkonium chloride Drugs 0.000 claims 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 1
- 229960002242 chlorocresol Drugs 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000011148 porous material Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003186 pharmaceutical solution Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102000005561 Human Isophane Insulin Human genes 0.000 description 1
- 108010084048 Human Isophane Insulin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- RWUKNUAHIRIZJG-AFEZEDKISA-M benzyl-dimethyl-[(z)-octadec-9-enyl]azanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC1=CC=CC=C1 RWUKNUAHIRIZJG-AFEZEDKISA-M 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229960004532 somatropin Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/16—Alumino-silicates
- B01J20/18—Synthetic zeolitic molecular sieves
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
| US09/051,752 US5936061A (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| CA002235767A CA2235767A1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| JP9516525A JPH11514920A (ja) | 1995-10-24 | 1996-10-15 | ポリペプチド溶液から防腐剤を除去するための疎水性ゼオライトの使用、シリンジおよび方法 |
| DE69623354T DE69623354T2 (de) | 1995-10-24 | 1996-10-15 | Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung |
| AT96935707T ATE222802T1 (de) | 1995-10-24 | 1996-10-15 | Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung |
| AU73524/96A AU693047B2 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| EP96935707A EP0956155B1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| PCT/SE1996/001306 WO1997015391A1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9503731D0 SE9503731D0 (sv) | 1995-10-24 |
| SE9503731L SE9503731L (sv) | 1997-04-25 |
| SE505274C2 true SE505274C2 (sv) | 1997-07-28 |
Family
ID=20399935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5936061A (ja) |
| EP (1) | EP0956155B1 (ja) |
| JP (1) | JPH11514920A (ja) |
| AT (1) | ATE222802T1 (ja) |
| AU (1) | AU693047B2 (ja) |
| CA (1) | CA2235767A1 (ja) |
| DE (1) | DE69623354T2 (ja) |
| SE (1) | SE505274C2 (ja) |
| WO (1) | WO1997015391A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000037364A1 (en) * | 1998-12-09 | 2000-06-29 | Ordio Ab | Purification of water |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802140D0 (sv) * | 1998-06-16 | 1998-06-16 | Ordio Ab | Zeoliter för adsorption |
| US6589224B2 (en) * | 2001-02-14 | 2003-07-08 | Renal Tech International Llc | Method of introducing fluids into a patient's body |
| US20050031708A1 (en) * | 2003-08-06 | 2005-02-10 | Portney Micah S. | Composition comprising a zeolite compound for treatment of diseases |
| US20090111751A1 (en) * | 2006-02-24 | 2009-04-30 | Novo Nordisk Health Care Ag | Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation |
| CA2574746A1 (en) * | 2007-01-22 | 2008-07-22 | Duoject Medical Systems Inc. | Syringe having venting structure and method for mixing two substances in a syringe |
| WO2009027478A2 (en) * | 2007-08-29 | 2009-03-05 | Novo Nordisk Health Care Ag | A method of removing preservatives from a liquid pharmaceutical preparation |
| US10130288B2 (en) | 2013-03-14 | 2018-11-20 | Cell and Molecular Tissue Engineering, LLC | Coated sensors, and corresponding systems and methods |
| US10405961B2 (en) | 2013-03-14 | 2019-09-10 | Cell and Molecular Tissue Engineering, LLC | Coated surgical mesh, and corresponding systems and methods |
| EP3179975A4 (en) * | 2014-08-13 | 2018-04-18 | University of Florida Research Foundation, Inc. | Preservative removal from eye drops |
| WO2016196516A1 (en) | 2015-06-03 | 2016-12-08 | William Kenneth Ward | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
| CN109069740B (zh) * | 2016-04-22 | 2021-10-29 | 伊莱利利公司 | 用于减少胰岛素中的间甲酚浓度的具有包含聚合吸着剂的组件的输注组 |
| EP3618890A1 (en) | 2017-05-01 | 2020-03-11 | Becton, Dickinson and Company | Filter for reducing phenolic compounds from insulin and related infusion and injection devices |
| MX2019014615A (es) | 2017-06-08 | 2020-02-07 | Amgen Inc | Dispositivo de administracion de farmacos accionado por par de torsion. |
| JP7517996B2 (ja) * | 2018-04-27 | 2024-07-17 | ベクトン・ディキンソン・アンド・カンパニー | 送達デバイスおよび吸着剤 |
| WO2019236653A1 (en) * | 2018-06-06 | 2019-12-12 | Entopsis Llc | System and method for removing phenolic preservations from insulin formulations |
| CN115397374A (zh) | 2019-12-19 | 2022-11-25 | 特清公司 | 从滴眼剂中去除防腐剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4240986A (en) * | 1979-02-23 | 1980-12-23 | Uop Inc. | Process for the separation of ortho-chloronitrobenzene |
| EP0021267B1 (en) * | 1979-06-18 | 1982-06-16 | PQ Corporation | Agglomerated zeolite ion exchanger |
| SE8902919L (sv) * | 1989-09-05 | 1991-03-05 | Haakan Eriksson | Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer |
| SE9201976D0 (sv) * | 1992-06-26 | 1992-06-26 | Tektolit Ab Haakan Eriksson | En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter |
| US5314855A (en) * | 1992-11-09 | 1994-05-24 | Akzo N.V. | Adsorbent compositions and methods of manufacture |
| US5585007A (en) * | 1994-12-07 | 1996-12-17 | Plasmaseal Corporation | Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
-
1995
- 1995-10-24 SE SE9503731A patent/SE505274C2/sv not_active IP Right Cessation
-
1996
- 1996-10-15 DE DE69623354T patent/DE69623354T2/de not_active Expired - Fee Related
- 1996-10-15 AU AU73524/96A patent/AU693047B2/en not_active Ceased
- 1996-10-15 US US09/051,752 patent/US5936061A/en not_active Expired - Fee Related
- 1996-10-15 JP JP9516525A patent/JPH11514920A/ja not_active Ceased
- 1996-10-15 EP EP96935707A patent/EP0956155B1/en not_active Expired - Lifetime
- 1996-10-15 CA CA002235767A patent/CA2235767A1/en not_active Abandoned
- 1996-10-15 AT AT96935707T patent/ATE222802T1/de not_active IP Right Cessation
- 1996-10-15 WO PCT/SE1996/001306 patent/WO1997015391A1/en active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000037364A1 (en) * | 1998-12-09 | 2000-06-29 | Ordio Ab | Purification of water |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2235767A1 (en) | 1997-05-01 |
| DE69623354D1 (de) | 2002-10-02 |
| WO1997015391A1 (en) | 1997-05-01 |
| JPH11514920A (ja) | 1999-12-21 |
| EP0956155B1 (en) | 2002-08-28 |
| EP0956155A1 (en) | 1999-11-17 |
| DE69623354T2 (de) | 2003-01-09 |
| AU7352496A (en) | 1997-05-15 |
| US5936061A (en) | 1999-08-10 |
| ATE222802T1 (de) | 2002-09-15 |
| SE9503731D0 (sv) | 1995-10-24 |
| AU693047B2 (en) | 1998-06-18 |
| SE9503731L (sv) | 1997-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE505274C2 (sv) | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning | |
| AU621148B2 (en) | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography | |
| DE69027187T2 (de) | Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen | |
| EP2249862B1 (en) | Method for producing a clottable concentrate of platelet growth factors | |
| AU698154B2 (en) | System for viral inactivation of blood | |
| JP2000513377A (ja) | プリオンのクロマトグラフィー除去方法 | |
| AU7650394A (en) | Displacement chromatography process and purified hemoglobin product | |
| Rock et al. | Distribution of di (2-ethylhexyl) phthalate and products in blood and blood components. | |
| EP2389942A1 (en) | Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof | |
| GB1597204A (en) | Process of preparing a serum protein composition for intravenous application | |
| RU2719468C2 (ru) | Способы очистки и/или вирусной инактивации | |
| SK54993A3 (en) | Imidoester cross-linked hemoglobin compositions | |
| EP1597271B1 (de) | Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung | |
| JPS59231097A (ja) | 均質ヒト免疫インターフェロンサブタイプ２１ｋおよびその製造法 | |
| Ramanathan et al. | Antiviral principles of propionibacteria-isolation and activity of propionins B and C | |
| CN100569287C (zh) | 犬静脉注射免疫球蛋白、其制备方法以及犬静脉注射免疫球蛋白制剂 | |
| EP1684868B1 (de) | Bekämpfung von hi-virus infektionen mit durch hypochlorige säure oxidiertem menschlichem blutplasma | |
| EP1048307B1 (en) | Dialysis membrane for the preparation of hematopoietic inhibiting factor containing compositions | |
| RU2140287C1 (ru) | Способ получения альбумина | |
| CA1303295C (en) | Immunosuppressor and method of extraction thereof | |
| Gebauer et al. | Ion-exchange chromatography separation of the detergent and the solvent from immunoglobulins after solvent–detergent treatment | |
| Galloway | Hepatitis A viral safety of plasma-derived factor VIII concentrate koate®-HP | |
| TW201319084A (zh) | 血小板源腦源性神經滋養因子濃厚液及其製備方法 | |
| Solutions et al. | Aluminium in Human | |
| DE10311106A1 (de) | Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |